Valuation: Kim Forest Enterprise Co., Ltd.

Market Cap 812M 25.16M 21.83M 20.44M 18.7M 35.3M 2.4B 35.77M 239M 93.86M 1.2B 94.46M 92.41M 3.99B P/E 2024
-7.91x
P/E 2025 -7.34x
Enterprise Value 1.07B 33.22M 28.83M 26.99M 24.69M 46.61M 3.16B 47.22M 316M 124M 1.58B 125M 122M 5.26B EV / Sales 2024
2.86x
EV / Sales 2025 2.43x
Free-Float
43.95%
Yield 2024 *
-
Yield 2025 -
1 day+3.46%
1 week+0.37%
Current month+0.75%
1 month-13.50%
3 months+5.08%
6 months-24.44%
Current year-24.01%
1 week 11.75
Extreme 11.75
14.05
1 month 11.75
Extreme 11.75
16.45
Current year 11.4
Extreme 11.4
18.5
1 year 11.4
Extreme 11.4
26.45
3 years 11.4
Extreme 11.4
48.1
5 years 11.4
Extreme 11.4
50.38
10 years 8.27
Extreme 8.27329
122.57
Manager TitleAgeSince
Chief Executive Officer - 01/07/2005
Director of Finance/CFO - 02/12/2013
Chief Tech/Sci/R&D Officer - 01/11/2016
Director TitleAgeSince
Chairman - 22/09/2014
Director/Board Member - 28/07/2004
Director/Board Member - 29/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
+3.46%+0.37%-25.69%-71.64% 24.29M
+1.08%-1.99%-42.20%-43.83% 606M
-1.25%+20.68%+126.61% - 401M
+2.82%+27.40%-31.27%+12.01% 122M
+5.74%-3.01%+0.39%+61.25% 94.9M
Average +2.37%+3.96%+5.57%-10.55% 249.66M
Weighted average by Cap. +0.90%+3.73%+16.65%-24.83%

Financials

2024 2025
Net sales 502M 15.54M 13.48M 12.62M 11.55M 21.8M 1.48B 22.09M 148M 57.96M 739M 58.33M 57.06M 2.46B 549M 17.01M 14.76M 13.82M 12.64M 23.87M 1.62B 24.18M 162M 63.46M 810M 63.87M 62.48M 2.69B
Net income -160M -4.95M -4.3M -4.02M -3.68M -6.95M -472M -7.04M -47.08M -18.48M -236M -18.59M -18.19M -785M -146M -4.54M -3.94M -3.69M -3.37M -6.37M -432M -6.45M -43.13M -16.93M -216M -17.03M -16.66M -719M
Net Debt 147M 4.54M 3.94M 3.69M 3.37M 6.37M 432M 6.45M 43.14M 16.93M 216M 17.04M 16.67M 719M 260M 8.06M 6.99M 6.55M 5.99M 11.31M 768M 11.46M 76.6M 30.06M 384M 30.25M 29.6M 1.28B
Logo Kim Forest Enterprise Co., Ltd.
KIM FOREST ENTERPRISE CO., LTD. is a Taiwan-based company mainly engaged in sale of biomedical products and provision of genetic testing and analysis services. The Company operates through two segments. The Biomedical Experiment Products segment is engaged in provision of laboratory equipment, reagents, supplies and equipment maintenance services. Main products include filter type microplate spectrophotometer, polymerase chain reaction (PCR) molecular biology experiment related equipment and reagents, equipment and reagents for separating cell, protein and nucleic acids, rapid DNA detection reagent and others. The Biotechnology and Genetic Testing segment is engaged in provision of whole genome sequencing (WGS) and whole exome sequencing(WES) tumor analysis services, RNA sequencing analysis, and new drug development system and check services.
Employees
-
Date Price Change Volume
06/08/26 NT$13.45 +3.46% 5,301
05/08/26 NT$13.00 -1.14% 25,052
04/08/26 NT$13.15 +0.77% 44,505
03/08/26 NT$13.05 -2.25% 17,617
31/07/26 NT$13.35 +1.14% 43,035
  1. Stock Market
  2. Stocks
  3. 6645 Stock